Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

85.300
+0.8000.95%
Volume:1.91M
Turnover:162.31M
Market Cap:48.08B
PE:-28.53
High:87.000
Open:83.200
Low:82.700
Close:84.500
52wk High:126.600
52wk Low:11.520
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.82
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.990
ROE:-40.42%
ROA:-9.72%
PB:18.92
PE(LYR):-28.53
PS:19.70

Loading ...

Hong Kong Stock Alert | REMEGEN (09995) Surges Over 7% as Telitacicept Enters Priority Review for IgA Nephropathy Treatment, Phase III Study Achieves Primary Endpoint

Stock News
·
Sep 29

HK Movers|Biotech Stocks Rose. Laekna Up 14%; RemeGen Rose 3%; Microport Up 2%; JW Therap, Zai Lab And Lepu Up 1%

Tiger Newspress
·
Sep 29

HK Movers | Biotech Shares Soar. Junshi Bio, JOINN, RemeGen up 6%; Asymchem, Hengrui Pharma up 3%

Tiger Newspress
·
Sep 25

Stock Track | REMEGEN Soars 8.36% as Company Secures 11 Presentations at ESMO 2025, Including Late-Breaking Abstract

Stock Track
·
Sep 25

REMEGEN Surges Over 7% in Early Trading as 11 Original Research Results Set for Major Presentation at ESMO 2025

Deep News
·
Sep 25

What RemeGen Co., Ltd.'s (HKG:9995) 32% Share Price Gain Is Not Telling You

Simply Wall St.
·
Sep 18

HK Movers | Biotech Stocks Jump With Biocytogen up 11%

Tiger Newspress
·
Sep 18

Stock Track | REMEGEN Soars 8.29% as Telitacicept gMG Study Selected for Prestigious Medical Conference

Stock Track
·
Sep 18

Hong Kong Stock Movement | REMEGEN (09995) Surges Over 8% as Telitacicept gMG China Phase III Clinical Study Selected for 2025 AANEM Oral Presentation

Stock News
·
Sep 18

After Trillion-Yuan GDP: How Will the Strongest Prefecture-Level City in Northern China Break Through Again?

Deep News
·
Sep 14

Hong Kong Stocks Movement | REMEGEN (09995) Surges Nearly 14% as Telitacicept's Marketing Application for Sjögren's Syndrome Treatment Accepted by CDE

Stock News
·
Sep 09

The "Hidden Champions" Driving Biopharmaceutical Manufacturing Process Revolution

Deep News
·
Sep 06

Hong Kong Stocks Movement | REMEGEN (09995) Surges Nearly 9% Again as Core Products Drive Revenue Growth, H1 Losses Narrow Significantly YoY

Stock News
·
Aug 29

Stock Track | REMEGEN Soars 8.86% Amid Broader Biotech Rally in Hong Kong

Stock Track
·
Aug 29

HK Movers | Biotech Stocks Surge With Cutia Therapeutics up 14%

Tiger Newspress
·
Aug 29

Hong Kong Stock Morning Brief | MIIT Supports Direct Satellite Phone Applications, MEITUAN-W (03690) H1 Revenue Up 14.7% YoY

Stock News
·
Aug 28

REMEGEN (09995): Telitacicept (Brand Name: Tai'ai®) Achieves Primary Endpoint in Phase A of China Phase III Clinical Study for IgA Nephropathy Treatment

Stock News
·
Aug 27

HK Movers | Biotech Stocks Rise Against Trend, RemeGen Up 7%

Tiger Newspress
·
Aug 26

RemeGen Narrows H1 Attributable Loss to 449.6 Million Yuan, Revenue Jumps to 1.09 Billion Yuan

MT Newswires Live
·
Aug 22

RemeGen's RC148 Wins Breakthrough Therapy Status in China

MT Newswires Live
·
Aug 20